Luo et al. [55] found that liver tissues from patients with nonalcoholic fatty liver disease and mice with high-fat diet- (HFD-) induced steatosis expressed higher levels of STING, while STING inhibition in macrophages decreased inflammation and the severity of liver fibrosis. Here, STING1 is linked to metabolic dysfunction-associated steatotic liver disease.